Taiwan · Delayed Price · Currency is TWD Jia Jie Biomedical Statistics
Total Valuation
TPEX:4109 has a market cap or net worth of TWD 1.35 billion. The enterprise value is 976.21 million.
| Market Cap | 1.35B |
| Enterprise Value | 976.21M |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | Sep 23, 2026 |
Share Statistics
TPEX:4109 has 118.74 million shares outstanding. The number of shares has increased by 10.74% in one year.
| Current Share Class | 118.74M |
| Shares Outstanding | 118.74M |
| Shares Change (YoY) | +10.74% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | n/a |
| Float | 91.55M |
Valuation Ratios
The trailing PE ratio is 437.63.
| PE Ratio | 437.63 |
| Forward PE | n/a |
| PS Ratio | 2.63 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 103.83 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 315.62 |
| EV / Sales | 1.90 |
| EV / EBITDA | 113.91 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.87 |
| Quick Ratio | 3.61 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 10.77 |
| Debt / FCF | -1.76 |
| Interest Coverage | -10.81 |
Financial Efficiency
Return on equity (ROE) is 0.22% and return on invested capital (ROIC) is -0.91%.
| Return on Equity (ROE) | 0.22% |
| Return on Assets (ROA) | -0.39% |
| Return on Invested Capital (ROIC) | -0.91% |
| Return on Capital Employed (ROCE) | -0.67% |
| Weighted Average Cost of Capital (WACC) | 3.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.28 |
| Inventory Turnover | 13.68 |
Taxes
| Income Tax | -924,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.30% in the last 52 weeks. The beta is -0.04, so TPEX:4109's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -28.30% |
| 50-Day Moving Average | 11.67 |
| 200-Day Moving Average | 13.30 |
| Relative Strength Index (RSI) | 41.50 |
| Average Volume (20 Days) | 141,397 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4109 had revenue of TWD 514.65 million and earned 3.09 million in profits. Earnings per share was 0.03.
| Revenue | 514.65M |
| Gross Profit | 138.70M |
| Operating Income | -11.51M |
| Pretax Income | 2.73M |
| Net Income | 3.09M |
| EBITDA | 5.93M |
| EBIT | -11.51M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 500.33 million in cash and 92.26 million in debt, with a net cash position of 408.07 million or 3.44 per share.
| Cash & Cash Equivalents | 500.33M |
| Total Debt | 92.26M |
| Net Cash | 408.07M |
| Net Cash Per Share | 3.44 |
| Equity (Book Value) | 1.66B |
| Book Value Per Share | 13.54 |
| Working Capital | 439.21M |
Cash Flow
In the last 12 months, operating cash flow was 13.04 million and capital expenditures -65.39 million, giving a free cash flow of -52.35 million.
| Operating Cash Flow | 13.04M |
| Capital Expenditures | -65.39M |
| Depreciation & Amortization | 17.44M |
| Net Borrowing | 87.36M |
| Free Cash Flow | -52.35M |
| FCF Per Share | -0.44 |
Margins
Gross margin is 26.95%, with operating and profit margins of -2.24% and 0.60%.
| Gross Margin | 26.95% |
| Operating Margin | -2.24% |
| Pretax Margin | 0.53% |
| Profit Margin | 0.60% |
| EBITDA Margin | 1.15% |
| EBIT Margin | -2.24% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.80%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.80% |
| Dividend Growth (YoY) | -60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1,919.43% |
| Buyback Yield | -10.74% |
| Shareholder Yield | -8.94% |
| Earnings Yield | 0.23% |
| FCF Yield | -3.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2019. It was a reverse split with a ratio of 0.8487883546.
| Last Split Date | Mar 21, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.8487883546 |
Scores
TPEX:4109 has an Altman Z-Score of 5.34 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.34 |
| Piotroski F-Score | 4 |